Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
14.64
+2.17 (17.40%)
At close: Apr 22, 2026, 4:00 PM EDT
14.35
-0.29 (-1.98%)
After-hours: Apr 22, 2026, 7:49 PM EDT
Polyrizon Market Cap
Polyrizon has a market cap or net worth of $26.1 million as of April 22, 2026. Its market cap has increased by 1,616.97% in one year.
Market Cap
26.10M
Enterprise Value
13.83M
1-Year Change
1,616.97%
Ranking
Category
Stock Price
$14.64
Market Cap Chart
Since the IPO on October 29, 2024, Polyrizon's market cap has increased from $6.50M to $26.10M, an increase of 301.50%. That is a compound annual growth rate of 156.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 22.23M | 64.28% |
| Dec 31, 2025 | 13.53M | 48.69% |
| Dec 31, 2024 | 9.10M | 40.00% |
| Oct 29, 2024 | 6.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Quince Therapeutics | 22.33M |
| Cocrystal Pharma | 20.82M |
| VYNE Therapeutics | 20.33M |
| Traws Pharma | 20.18M |
| Allarity Therapeutics | 19.46M |
| Citius Pharmaceuticals | 19.21M |
| OSR Holdings | 18.88M |
| Pasithea Therapeutics | 18.52M |